Selected research
Industry Growth & Trends
Global Yellow Fever Vaccines Industry Growth and Trends Forecast to 2032
Market perspective
The global Yellow Fever Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Yellow Fever Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Yellow Fever Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Yellow Fever Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Yellow Fever Vaccines include Bio-Manguinhos, FSUE Chumakov, Institut Pasteur de Dakar and Sanofi Pasteur, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Yellow Fever Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Yellow Fever Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Yellow Fever Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Yellow Fever Vaccines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Yellow Fever Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Yellow Fever Vaccines Market by Company
Bio-Manguinhos
FSUE Chumakov
Institut Pasteur de Dakar
Sanofi Pasteur
Yellow Fever Vaccines Segment by Type
Institonal Contributions
Private Purchase
Others
Yellow Fever Vaccines Segment by Application
Routine Immunization
Travelers
Other
Yellow Fever Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yellow Fever Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Yellow Fever Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yellow Fever Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Yellow Fever Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Yellow Fever Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Institonal Contributions
- Private Purchase
- Others
Applications
- Routine Immunization
- Travelers
- Other
Companies covered
- Bio-Manguinhos
- FSUE Chumakov
- Institut Pasteur de Dakar
- Sanofi Pasteur
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Yellow Fever Vaccines Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Yellow Fever Vaccines Sales Estimates and Forecasts (2021-2032)
- 1.3 Yellow Fever Vaccines Market by Type
- 1.3.1 Institonal Contributions
- 1.3.2 Private Purchase
- 1.3.3 Others
- 1.4 Global Yellow Fever Vaccines Market Size by Type
- 1.4.1 Global Yellow Fever Vaccines Market Size Overview by Type (2021-2032)
- 1.4.2 Global Yellow Fever Vaccines Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Yellow Fever Vaccines Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Yellow Fever Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Yellow Fever Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Yellow Fever Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Yellow Fever Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Yellow Fever Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Yellow Fever Vaccines Industry Trends
- 2.2 Yellow Fever Vaccines Industry Drivers
- 2.3 Yellow Fever Vaccines Industry Opportunities and Challenges
- 2.4 Yellow Fever Vaccines Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Yellow Fever Vaccines Revenue (2021-2026)
- 3.2 Global Top Players by Yellow Fever Vaccines Sales (2021-2026)
- 3.3 Global Top Players by Yellow Fever Vaccines Price (2021-2026)
- 3.4 Global Yellow Fever Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Yellow Fever Vaccines Major Company Production Sites & Headquarters
- 3.6 Global Yellow Fever Vaccines Company, Product Type & Application
- 3.7 Global Yellow Fever Vaccines Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Yellow Fever Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Yellow Fever Vaccines Players Market Share by Revenue in 2025
- 3.8.3 2025 Yellow Fever Vaccines Tier 1, Tier 2, and Tier 3
4 Yellow Fever Vaccines Regional Status and Outlook
- 4.1 Global Yellow Fever Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Yellow Fever Vaccines Historic Market Size by Region
- 4.2.1 Global Yellow Fever Vaccines Sales in Volume by Region (2021-2026)
- 4.2.2 Global Yellow Fever Vaccines Sales in Value by Region (2021-2026)
- 4.2.3 Global Yellow Fever Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Yellow Fever Vaccines Forecasted Market Size by Region
- 4.3.1 Global Yellow Fever Vaccines Sales in Volume by Region (2027-2032)
- 4.3.2 Global Yellow Fever Vaccines Sales in Value by Region (2027-2032)
- 4.3.3 Global Yellow Fever Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Yellow Fever Vaccines by Application
- 5.1 Yellow Fever Vaccines Market by Application
- 5.1.1 Routine Immunization
- 5.1.2 Travelers
- 5.1.3 Other
- 5.2 Global Yellow Fever Vaccines Market Size by Application
- 5.2.1 Global Yellow Fever Vaccines Market Size Overview by Application (2021-2032)
- 5.2.2 Global Yellow Fever Vaccines Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Yellow Fever Vaccines Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Yellow Fever Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Yellow Fever Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Yellow Fever Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Yellow Fever Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Yellow Fever Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Bio-Manguinhos
- 6.1.1 Bio-Manguinhos Company Information
- 6.1.2 Bio-Manguinhos Business Overview
- 6.1.3 Bio-Manguinhos Yellow Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Bio-Manguinhos Yellow Fever Vaccines Product Portfolio
- 6.1.5 Bio-Manguinhos Recent Developments
- 6.2 FSUE Chumakov
- 6.2.1 FSUE Chumakov Company Information
- 6.2.2 FSUE Chumakov Business Overview
- 6.2.3 FSUE Chumakov Yellow Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 FSUE Chumakov Yellow Fever Vaccines Product Portfolio
- 6.2.5 FSUE Chumakov Recent Developments
- 6.3 Institut Pasteur de Dakar
- 6.3.1 Institut Pasteur de Dakar Company Information
- 6.3.2 Institut Pasteur de Dakar Business Overview
- 6.3.3 Institut Pasteur de Dakar Yellow Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Institut Pasteur de Dakar Yellow Fever Vaccines Product Portfolio
- 6.3.5 Institut Pasteur de Dakar Recent Developments
- 6.4 Sanofi Pasteur
- 6.4.1 Sanofi Pasteur Company Information
- 6.4.2 Sanofi Pasteur Business Overview
- 6.4.3 Sanofi Pasteur Yellow Fever Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sanofi Pasteur Yellow Fever Vaccines Product Portfolio
- 6.4.5 Sanofi Pasteur Recent Developments
7 North America by Country
- 7.1 North America Yellow Fever Vaccines Sales by Country
- 7.1.1 North America Yellow Fever Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Yellow Fever Vaccines Sales by Country (2021-2026)
- 7.1.3 North America Yellow Fever Vaccines Sales Forecast by Country (2027-2032)
- 7.2 North America Yellow Fever Vaccines Market Size by Country
- 7.2.1 North America Yellow Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Yellow Fever Vaccines Market Size by Country (2021-2026)
- 7.2.3 North America Yellow Fever Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Yellow Fever Vaccines Sales by Country
- 8.1.1 Europe Yellow Fever Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Yellow Fever Vaccines Sales by Country (2021-2026)
- 8.1.3 Europe Yellow Fever Vaccines Sales Forecast by Country (2027-2032)
- 8.2 Europe Yellow Fever Vaccines Market Size by Country
- 8.2.1 Europe Yellow Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Yellow Fever Vaccines Market Size by Country (2021-2026)
- 8.2.3 Europe Yellow Fever Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Yellow Fever Vaccines Sales by Country
- 9.1.1 Asia-Pacific Yellow Fever Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Yellow Fever Vaccines Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Yellow Fever Vaccines Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Yellow Fever Vaccines Market Size by Country
- 9.2.1 Asia-Pacific Yellow Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Yellow Fever Vaccines Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Yellow Fever Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Yellow Fever Vaccines Sales by Country
- 10.1.1 South America Yellow Fever Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Yellow Fever Vaccines Sales by Country (2021-2026)
- 10.1.3 South America Yellow Fever Vaccines Sales Forecast by Country (2027-2032)
- 10.2 South America Yellow Fever Vaccines Market Size by Country
- 10.2.1 South America Yellow Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Yellow Fever Vaccines Market Size by Country (2021-2026)
- 10.2.3 South America Yellow Fever Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Yellow Fever Vaccines Sales by Country
- 11.1.1 Middle East and Africa Yellow Fever Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Yellow Fever Vaccines Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Yellow Fever Vaccines Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Yellow Fever Vaccines Market Size by Country
- 11.2.1 Middle East and Africa Yellow Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Yellow Fever Vaccines Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Yellow Fever Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Yellow Fever Vaccines Value Chain Analysis
- 12.1.1 Yellow Fever Vaccines Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Yellow Fever Vaccines Production Mode & Process
- 12.2 Yellow Fever Vaccines Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Yellow Fever Vaccines Distributors
- 12.2.3 Yellow Fever Vaccines Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst